Skip to NavigationSkip to content

Vertex ousts COO Ian Smith over 'personal behaviour'

Published on 24/01/19 at 10:27am

Boston-based firm Vertex Pharmaceuticals has fired Chief Operating Officer (COO) and interim Chief Financial Officer (CFO) Ian Smith. Smith’s termination, which is said to be unrelated to the company’s financial and business performance is effective immediately.

The company cited Smith’s “personal behaviour” which it claimed “violated Vertex's Code of Conduct and values”.

Dr Jeffrey Leiden, Chairman, President and Chief Executive Officer of Vertex, commented: “At Vertex, we are deeply committed to our culture of diversity, inclusion and respect, and we insist that all of our employees, regardless of their seniority, live our values and adhere to our Code of Conduct. This decision was not related to any conduct concerning the company's operations or finances.”

 “Vertex has a strong management team in place, as well as a deep bench. In 2019 and beyond, I am confident that we will continue to successfully execute the company’s long-standing strategy to bring transformative treatments to all people living with cystic fibrosis (CF) and advance our diverse pipeline of medicines for other serious diseases,” Leiden added.

“Making a difference in the lives of patients, their families and their caregivers is our true north, and our commitment to this ideal is unwavering.”

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches